tiprankstipranks
Trending News
More News >
NextCell Pharma AB (DE:65G)
FRANKFURT:65G
Germany Market

NextCell Pharma AB (65G) Ratios

Compare
0 Followers

NextCell Pharma AB Ratios

DE:65G's free cash flow for Q2 2025 was kr0.21. For the 2025 fiscal year, DE:65G's free cash flow was decreased by kr and operating cash flow was kr-2.52. See a summary of the company’s cash flow.
Ratios
TTM
Sep 24Sep 23Sep 22Sep 21
Liquidity Ratios
Current Ratio
6.67 6.67 15.40 37.02 11.97
Quick Ratio
6.60 6.60 15.29 37.02 11.97
Cash Ratio
4.96 4.96 14.01 35.17 10.10
Solvency Ratio
-3.00 -3.00 -3.69 -4.36 -4.86
Operating Cash Flow Ratio
-4.35 -4.35 -4.81 -6.46 -8.72
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
kr 97.64Mkr 54.17Mkr 97.64Mkr 140.95Mkr 22.48M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.17 1.17 1.08 1.04 1.14
Debt Service Coverage Ratio
-14.42K -14.42K -2.49K -3.20K -1.96K
Interest Coverage Ratio
-14.58K -14.58K -2.59K -3.28K -2.00K
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
2.85 1.27 2.85 5.75 1.27
Profitability Margins
Gross Profit Margin
-8.75%-8.75%-398.31%-371.36%-291.00%
EBIT Margin
-393.62%-393.62%-618.04%-627.53%-495.75%
EBITDA Margin
-389.22%-389.22%-610.10%-618.88%-484.85%
Operating Profit Margin
-405.42%-405.42%-626.68%-634.48%-496.60%
Pretax Profit Margin
-393.65%-393.65%-618.28%-627.73%-495.99%
Net Profit Margin
-393.65%-393.65%-609.88%-627.92%-496.24%
Continuous Operations Profit Margin
-393.65%-393.65%-618.28%-627.73%-495.99%
Net Income Per EBT
100.00%100.00%98.64%100.03%100.05%
EBT Per EBIT
97.10%97.10%98.66%98.94%99.88%
Return on Assets (ROA)
-27.34%-44.82%-27.34%-15.78%-59.41%
Return on Equity (ROE)
-29.50%-52.57%-29.50%-16.37%-67.47%
Return on Capital Employed (ROCE)
-29.75%-52.07%-29.75%-16.37%-64.14%
Return on Invested Capital (ROIC)
-29.35%-53.63%-29.35%-16.37%-64.17%
Return on Tangible Assets
-27.34%-44.82%-27.34%-15.78%-59.41%
Earnings Yield
-7.81%-16.08%-7.81%-2.79%-4.71%
Efficiency Ratios
Receivables Turnover
0.00 0.00 3.14 2.81 4.35
Payables Turnover
12.34 12.34 14.47 14.39 29.18
Inventory Turnover
13.91 13.91 36.31 18.44M 13.94M
Fixed Asset Turnover
0.75 0.75 0.56 1.35 1.36
Asset Turnover
0.11 0.11 0.04 0.03 0.12
Working Capital Turnover Ratio
0.13 0.13 0.05 0.05 0.16
Cash Conversion Cycle
100.89 -3.35 100.89 104.38 71.48
Days of Sales Outstanding
116.06 0.00 116.06 129.74 83.99
Days of Inventory Outstanding
10.05 26.24 10.05 <0.01 <0.01
Days of Payables Outstanding
25.22 29.59 25.22 25.37 12.51
Operating Cycle
126.11 26.24 126.11 129.74 83.99
Cash Flow Ratios
Operating Cash Flow Per Share
-0.64 -0.64 -0.48 -0.42 -0.48
Free Cash Flow Per Share
-0.70 -0.70 -0.59 -0.43 -0.50
CapEx Per Share
0.06 0.06 0.11 0.01 0.02
Free Cash Flow to Operating Cash Flow
1.09 1.09 1.23 1.03 1.04
Dividend Paid and CapEx Coverage Ratio
-10.69 -10.69 -4.39 -35.23 -24.09
Capital Expenditure Coverage Ratio
-10.69 -10.69 -4.39 -35.23 -24.09
Operating Cash Flow Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
-4.33 -4.33 -5.96 -6.54 -5.32
Free Cash Flow Yield
-9.37%-19.36%-9.37%-2.98%-5.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-6.22 -6.22 -12.81 -35.90 -21.25
Price-to-Sales (P/S) Ratio
24.48 24.48 78.12 225.44 105.43
Price-to-Book (P/B) Ratio
3.27 3.27 3.78 5.88 14.33
Price-to-Free Cash Flow (P/FCF) Ratio
-5.17 -5.17 -10.67 -33.53 -19.03
Price-to-Operating Cash Flow Ratio
-5.65 -5.65 -13.11 -34.48 -19.82
Price-to-Earnings Growth (PEG) Ratio
-0.42 -0.42 -0.52 3.99 0.55
Price-to-Fair Value
3.27 3.27 3.78 5.88 14.33
Enterprise Value Multiple
-5.02 -5.02 -9.96 -30.68 -20.48
Enterprise Value
339.50M 197.51M 339.50M 742.78M 353.88M
EV to EBITDA
-9.96 -5.02 -9.96 -30.68 -20.48
EV to Sales
60.75 19.53 60.75 189.87 99.27
EV to Free Cash Flow
-8.30 -4.12 -8.30 -28.24 -17.92
EV to Operating Cash Flow
-10.19 -4.51 -10.19 -29.04 -18.66
Tangible Book Value Per Share
1.10 1.10 1.68 2.47 0.66
Shareholders’ Equity Per Share
1.10 1.10 1.68 2.47 0.66
Tax and Other Ratios
Effective Tax Rate
-0.03 -0.03 0.01 >-0.01 >-0.01
Revenue Per Share
0.15 0.15 0.08 0.06 0.09
Net Income Per Share
-0.58 -0.58 -0.50 -0.40 -0.45
Tax Burden
0.99 1.00 0.99 1.00 1.00
Interest Burden
1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 2.17 2.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.95 1.07 0.95 1.03 1.07
Currency in SEK
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis